On October 8, 2025, Prenetics Global Limited announced the launch of Daily Ultimate Longevity, the first supplement scientifically formulated to target all 12 hallmarks of aging. The product is part of the IM8 Health brand, co‑founded by David Beckham, and is available exclusively at IM8health.com. The launch is positioned as a milestone in the company’s rapid consumer‑health expansion, following IM8’s record growth to $6.6 million in monthly revenue in September 2025.
Daily Ultimate Longevity is a powder‑based formulation that delivers 1,100 % more active ingredient capacity than standard capsules. It incorporates a proprietary 5‑Complex System developed with doctors and scientists from Mayo Clinic and a former NASA chief scientist. The five complexes target cellular senescence, mitochondrial dysfunction, DNA repair, and other key aging pathways identified in the landmark Cell journal research on the 12 hallmarks of aging.
The longevity market is projected to reach $314 billion by 2030, and IM8’s new product is priced at $149 for a one‑time purchase and $119 per month for a subscription. The launch follows a trajectory that saw IM8’s monthly revenue scale from roughly $600,000 to $6.6 million in September, with 350,000 customer purchases and over 10 million servings delivered. The company estimates the new supplement will help IM8 reach $100 million in annual recurring revenue within its first year of operation.
Prenetics’ financial foundation supports continued innovation: the company holds more than $90 million in liquid assets, including approximately $60 million in cash and 255.4 Bitcoin valued at about $31.6 million. With a debt‑free balance sheet and a clear path to profitability in early 2026, the launch of Daily Ultimate Longevity adds a high‑margin product to a portfolio that already includes the popular Daily Ultimate Essentials.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.